Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Appian
APPN
$2.48B
| $37.5M | ﹤0.01% |
938,539
+29,339
| +3% | +$1.02M |
|
1552
Protagonist Therapeutics
PTGX
$9.44B
| $37.4M | ﹤0.01% |
1,293,739
+45,455
| +4% | +$1.24M |
|
1553
Leonardo DRS
DRS
$12B
| $37.4M | ﹤0.01% |
1,692,156
+46,475
| +3% | +$965K |
|
1554
Descartes Systems
DSGX
$6.82B
| $37.4M | ﹤0.01% |
406,742
+15,712
| +4% | +$1.38M |
|
1555
Global Net Lease
GNL
$1.95B
| $37.2M | ﹤0.01% |
4,786,782
+143,032
| +3% | +$1.17M |
|
|
AMWD
1556
DELISTED
American Woodmark
AMWD
| $37.2M | ﹤0.01% |
365,747
+6,010
| +2% | +$566K |
|
1557
Dyne Therapeutics
DYN
$4.9B
| $37.1M | ﹤0.01% |
1,307,604
+374,766
| +40% | +$8.48M |
|
1558
US Physical Therapy
USPH
$1.22B
| $36.9M | ﹤0.01% |
327,250
+12,892
| +4% | +$1.29M |
|
1559
Virtus Investment Partners
VRTS
$1.1B
| $36.9M | ﹤0.01% |
148,711
-3,373
| -2% | -$799K |
|
1560
New Fortress Energy
NFE
$101M
| $36.8M | ﹤0.01% |
1,202,470
+39,706
| +3% | +$1.3M |
|
1561
Stantec
STN
$8.39B
| $36.7M | ﹤0.01% |
440,865
+35,017
| +9% | +$2.88M |
|
1562
TTM Technologies
TTMI
$14.5B
| $36.7M | ﹤0.01% |
2,345,168
+52,029
| +2% | +$772K |
|
1563
Gulfport Energy Corp
GPOR
$2.88B
| $36.6M | ﹤0.01% |
228,830
+2,598
| +1% | +$356K |
|
1564
IonQ
IONQ
$16.6B
| $36.6M | ﹤0.01% |
3,667,321
+133,117
| +4% | +$1.42M |
|
1565
Oxford Industries
OXM
$552M
| $36.5M | ﹤0.01% |
324,742
+10,487
| +3% | +$1.05M |
|
1566
Allegro MicroSystems
ALGM
$8.16B
| $36.5M | ﹤0.01% |
1,351,833
+46,322
| +4% | +$1.34M |
|
1567
Kura Oncology
KURA
$850M
| $36.4M | ﹤0.01% |
1,707,274
+51,265
| +3% | +$997K |
|
1568
Cimpress
CMPR
$2.31B
| $36.4M | ﹤0.01% |
410,649
+14,137
| +4% | +$1.2M |
|
1569
Hawkins
HWKN
$2.71B
| $36.3M | ﹤0.01% |
472,858
+21,161
| +5% | +$1.45M |
|
1570
Ingevity
NGVT
$2.68B
| $36.3M | ﹤0.01% |
760,638
+22,107
| +3% | +$994K |
|
1571
Extreme Networks
EXTR
$3.15B
| $36.3M | ﹤0.01% |
3,144,084
+112,530
| +4% | +$1.53M |
|
1572
Coursera
COUR
$1.54B
| $36.2M | ﹤0.01% |
2,582,144
+110,628
| +4% | +$1.88M |
|
|
VGR
1573
DELISTED
Vector Group Ltd.
VGR
| $36.2M | ﹤0.01% |
3,301,866
+101,763
| +3% | +$1.11M |
|
|
DVAX
1574
DELISTED
Dynavax Technologies
DVAX
| $36.2M | ﹤0.01% |
2,914,693
+93,795
| +3% | +$1.22M |
|
|
ALPN
1575
DELISTED
Alpine Immune Sciences Inc
ALPN
| $36.1M | ﹤0.01% |
910,599
+146,252
| +19% | +$4.32M |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.